Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-10 Plenge Robert M EVP, Chief Research Officer Option exercise +2,342 18,728
2026-03-10 Plenge Robert M EVP, Chief Research Officer Other disposition −253 18,475
2026-03-10 Plenge Robert M EVP, Chief Research Officer Shares withheld for taxes −927 $60.13 $56K 17,548
2026-03-10 Plenge Robert M EVP, Chief Research Officer Option exercise +14,052 31,600
2026-03-10 Plenge Robert M EVP, Chief Research Officer Other disposition −6,900 24,700
2026-03-10 Plenge Robert M EVP, Chief Research Officer Shares withheld for taxes −3,172 $60.13 $191K 21,528
2026-03-10 Plenge Robert M EVP, Chief Research Officer Option exercise · Market Share Units −1,107 0
2026-03-10 Plenge Robert M EVP, Chief Research Officer Option exercise · Market Share Units −2,342 2,342
2026-03-10 Plenge Robert M EVP, Chief Research Officer Option exercise · Performance Shares −14,052 0
2026-03-10 Plenge Robert M EVP, Chief Research Officer Grant or award · Market Share Units +17,959 17,959
2026-03-10 Plenge Robert M EVP, Chief Research Officer Grant or award · Performance Shares +26,939 26,939
2026-03-10 Hickey Benjamin President, RayzeBio Org. Grant or award · Market Share Units +11,429 11,429
2026-03-10 Hickey Benjamin President, RayzeBio Org. Grant or award · Performance Shares +17,143 17,143
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Option exercise +6,618 7,800
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Other disposition −743 7,057
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Shares withheld for taxes −3,006 $60.13 $181K 4,051
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Option exercise +6,733 10,784
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Other disposition −727 10,057
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Shares withheld for taxes −3,073 $60.13 $185K 6,984
2026-03-10 BOERNER CHRISTOPHER S. Chief Executive Officer Option exercise +40,398 47,382

Page 10 of 40 · 799 trades